Fig. 1From: Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapyTEM image of FeS2 (A) and CF (B) with the inset image showing the single image of corresponding materials. C Western blotting was used to measure the EXO markers CD9 and CD63. D Statistical graph of the measured diameter of FeS2 and CF. E Zeta potential values for FeS2, CV, and CF nanovesicles. F UV − vis absorbance spectra and color changes of TMB in different reaction systemsBack to article page